pH-Sensitive stimulus-responsive nanocarriers for targeted delivery of therapeutic agents

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 8, Issue 5, 2016, Pages 696-716

  Karimi, Mahdi ^a   Eslami, Masoud ^b   Sahandi Zangabad, Parham ^a,b   Mirab, Fereshteh ^b   Farajisafiloo, Negar ^b   Shafaei, Zahra ^c   Ghosh, Deepanjan ^d   Bozorgomid, Mahnaz ^e   Dashkhaneh, Fariba ^d   Hamblin, Michael R ^f,g,h  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHARIF UNIVERSITY OF TECHNOLOGY   (Iran)

^c KHARAZMI UNIVERSITY   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e ISLAMIC AZAD UNIVERSITY   (Iran)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMOLECULES; DISEASE CONTROL; GENE THERAPY; MAGNETIC LEVITATION VEHICLES; METAL IONS; METALS; PH SENSORS; PROTEINS; REDOX REACTIONS;

ANTI-CANCER AGENTS; DELIVERY VEHICLE; DIFFERENT MECHANISMS; MECHANICAL FORCE; PHYSIOLOGICAL DIFFERENCES; STIMULI-RESPONSIVE; TARGETED DELIVERY; THERAPEUTIC AGENTS;

NANOSYSTEMS;

DRUG; INORGANIC NANOPARTICLE; LIPOSOME; NANOCARRIER; NANOPARTICLE; PH SENSITIVE NANOCARRIER; POLYMERIC MICELLE; POLYMERIC NANOPARTICLE; PRODRUG; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

CANCER CELL; CELL PH; DRUG CONJUGATION; DRUG DESIGN; DRUG RELEASE; DRUG SOLUBILITY; EXTRACELLULAR PH; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PH; POLYMERIZATION; PRIORITY JOURNAL; REVIEW;

EID: 84981729562     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1389     Document Type: Review

References (150)

1. Ding Z, Liu Z, Hu J, Swaddiwudhipong S, Yang Z. Inhomogeneous large deformation study of temperature-sensitive hydrogel. Int J Solids Struct 2013, 50:2610–2619.
2. Tomar LK, Tyagi C, Choonara YE, Kumar P, Pillay V. Rheological and swelling behavior of pH sensitive hydrogel particles. APCBEE Procedia 2014, 9:192–196.
3. Dong K, Dong Y, You C, Xu W, Huang X, Yan Y, Zhang L, Wang K, Xing J. Assessment of the safety, targeting, and distribution characteristics of a novel pH-sensitive hydrogel. Colloids Surf B Biointerfaces 2014, 123:965–973.
4. Chiang C-Y, Chu C-C. Synthesis of photoresponsive hybrid alginate hydrogel with photo-controlled release behavior. Carbohydr Polym 2014, 119:18–25.
5. Indermun S, Choonara YE, Kumar P, du Toit LC, Modi G, Luttge R, Pillay V. An interfacially plasticized electro-responsive hydrogel for transdermal electro-activated and modulated (TEAM) drug delivery. Int J Pharm 2014, 462:52–65.
6. Karthik S, Puvvada N, Kumar BN, Rajput S, Pathak A, Mandal M, Singh ND. Photoresponsive coumarin-tethered multifunctional magnetic nanoparticles for release of anticancer drug. ACS Appl Mater Interfaces 2013, 5:5232–5238.
7. Cavalieri F, Micheli L, Kaliappan S, Teo BM, Zhou M, Palleschi G. Antimicrobial and biosensing ultrasound responsive lysozyme-shelled microbubbles. ACS Appl Mater Interfaces 2013, 5:464–471.
8. Rapoport NY, Kennedy AM, Shea JE, Scaife CL, Nam K-H. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. J Control Release 2009, 138:268–276.
9. Lai F, Li H, Luo R. Chemo-electro-mechanical modeling of ionic-strength-sensitive hydrogel: Influence of Young's modulus. Int J Solids Struct 2010, 47:3141–3149.
10. Ballauff M, Lu Y. ‘Smart’ nanoparticles: preparation, characterization and applications. Polymer (Guildf) 2007, 48:1815-1823.
11. Liua J, Huanga Y, Kumara A, Tanc A, Jina S, Mozhia A, Lianga X. pH-sensitive nano-systems for drug delivery in cancer therapy. Biotechnol Adv 2014, 32:693–710.
12. Bergbreiter D, Brenda C, Yun-Shan L, Caraway WJ. Poly(N-isopropylacrylamide) soluble polymer supports in catalysis and synthesis. Macromolecules 1998, 31:6053–6062.
13. Kim JH, Yoon LS, Nam DH, Ryu J, Ku SH, Park CB. Biosensors and bioelectronics self-assembled, photoluminescent peptide hydrogel as a versatile platform for enzyme-based optical biosensors. Biosens Bioelectron 2011, 26:1860–1865.
14. Kim D-Y, Kim HJ. pH-sensitive optode membrane covalently incorporated with an ICT dye for low pH values. Sens Actuators B Chem 2015, 206:508–515.
15. Engin K, Leeper DB, Cater JR, Thistlethwaite AJ, Tupchong L, McFarlane JD. Extracellular pH distribution in human tumours. Int J Hyperthermia 1995, 11:211–216.
16. Iemma F, Spizzirri UG, Puoci F, Muzzalupo R, Trombino S, Cassano R, Leta S, Picci N. pH-sensitive hydrogels based on bovine serum albumin for oral drug delivery. Int J Pharm 2006, 312:151–157.
17. Shaikh RP, Pillay V, Choonara YE, du Toit LC, Ndesendo VM, Bawa P, Cooppan S. A review of multi-responsive membranous systems for rate-modulated drug delivery. AAPS PharmSciTech 2010, 11:441–459.
18. Alvarez-Lorenzo C, Concheiro A. Smart drug delivery systems: from fundamentals to the clinic. Chem Commun 2014, 50:7743–7765.
19. Alvarez-Lorenzo C, Concheiro A. Chapter 1: From drug dosage forms to intelligent drug delivery systems: a change of paradigm. Smart Mater Drug Deliv 2013, 1:1. doi:10.1039/9781849736800-00001.
20. Binauld S, Stenzel MH. Acid-degradable polymers for drug delivery: a decade of innovation. Chem Commun 2013, 49:2082–102.
21. Prabaharan M, Mano JF. Stimuli-responsive hydrogels based on polysaccharides incorporated with thermo-responsive polymers as novel biomaterials. Macromol Biosci 2006, 6:991–1008.
22. De Las Heras Alarcon C, Pennadam S, Alexander C. Stimuli responsive polymers for biomedical applications. Chem Soc Rev 2005, 34:276–285.
23. Schmaljohann D. Thermo- and pH-responsive polymers in drug delivery. Adv Drug Deliv Rev 2006, 58:1655–1670.
24. d'Angelo I, Conte C, Miro A, Quaglia F, Ungaro F. Core-shell nanocarriers for cancer therapy. Part I: biologically oriented design rules. Expert Opin Drug Deliv 2014, 11:283–297.
25. Nicolas J, Mura S, Brambilla D, Mackiewicz N, Couvreur P. Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. Chem Soc Rev 2013, 42:1147–1235.
26. Bickerton S, Jiwpanich S, Thayumanavan S. Interconnected roles of scaffold hydrophobicity, drug loading, and encapsulation stability in polymeric nanocarriers. Mol Pharm 2012, 9:3569–3578.
27. Kamaly N, Xiao Z, Valencia PM, Radovic-Moreno AF, Farokhzad OC. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev 2012, 41:2971–3010.
28. Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nat Mater 2013, 12:991–1003.
29. Cheng R, Meng F, Deng C, Klok H-A, Zhong Z. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials 2013, 34:3647–3657.
30. Reisner E, Arion VB, Guedes da Silva MF, Lichtenecker R, Eichinger A, Keppler BK, Kukushkin VY, Pombeiro AJ. Tuning of redox potentials for the design of ruthenium anticancer drugs − an electrochemical study of [trans-RuCl 4 L (DMSO)] - and indazole. Inorg Chem 2004, 43:7083–7093.
31. Hu J, Zhang G, Liu S. Enzyme-responsive polymeric assemblies, nanoparticles and hydrogels. Chem Soc Rev 2012, 41:5933–5949.
32. Vyas SP, Singh A, Sihorkar V. Ligand-receptor-mediated drug delivery: an emerging paradigm in cellular drug targeting. Crit Rev Ther Drug Carrier Syst 2001, 18(1):1–76.
33. Hayashi K, Ono K, Suzuki H, Sawada M, Moriya M, Sakamoto W, Yogo T. High-frequency, magnetic-field-responsive drug release from magnetic nanoparticle/organic hybrid based on hyperthermic effect. ACS Appl Mater Interfaces 2010, 2:1903–1911.
34. Prabhakar U, Maeda H, Jain RK, Sevick-Muraca EM, Zamboni W, Farokhzad OC, Barry ST, Gabizon A, Grodzinski P, Blakey DC. Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res 2013, 73:2412–2417.
35. Li Y, Wang J, Wientjes MG, Au JL-S. Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor. Adv Drug Deliv Rev 2012, 64:29–39.
36. Less JR, Skalak TC, Sevick EM, Jain RK. Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions; 1991.
37. Heldin C-H, Rubin K, Pietras K, Ostman A. High interstitial fluid pressure - an obstacle in cancer therapy. Nat Rev Cancer 2004, 4:806–813.
38. Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res 1987, 500:3039–3052.
39. Rofstad EK, Galappathi K, Mathiesen BS. Tumor interstitial fluid pressure-a link between tumor hypoxia, microvascular density, and lymph node metastasis. Neoplasia 2014, 16:586–594.
40. Cabral H, Matsumoto Y, Mizuno K, Chen Q, Murakami M, Kimura M, Terada Y, Kano MR, Miyazono K, Uesaka M et al. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol 2011, 6:815–823.
41. Warren BA. The vascular morphology of tumors. Tumor Blood Circ 1979, 645:1–48.
42. Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003, 3:401–410.
43. Curti BD, Urba WJ, Alvord WG, Janik JE, Smith JW 2nd, Madara K, Longo DL. Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients: changes during treatment. Cancer Res 1993, 53 (10):2204–2207.
44. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986, 46(12 part 1):6387–6392.
45. Maeda H, Sawa T, Konno T. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release 2001, 74:47–61.
46. Roberts WG, Palade GE. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res 1997, 57:765–772.
47. Ivanovic Z. Hypoxia or in situ normoxia: The stem cell paradigm. J Cell Physiol 2009, 219:271–275.
48. Höckel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001, 93:266–276.
49. Elsabahy M, Wooley KL. Design of polymeric nanoparticles for biomedical delivery applications. Chem Soc Rev 2012, 41:2545–2561.
50. Mahmoudi M, Lynch I, Ejtehadi MR, Monopoli MP, Bombelli FB, Laurent S. Protein à nanoparticle interactions: opportunities and challenges. 2011, 111(9):5610–5637.
51. Monopoli MP, Aberg C, Salvati A, Dawson KA. Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol 2012, 7:779–786.
52. Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008, 7:771–782.
53. Volk T, Jaihdel E, Fortmeyer HP, Glisenkampl K, Rajewskyl MF. pH in human tumour xenografts: effect of intravenous administration of glucose. Br J Cancer 1993, 68(3):492–500.
54. Criscione JM, Le BL, Stern E, Brennan M, Rahner C, Papademetris X, Fahmy TM. Self-assembly of pH-responsive fluorinated dendrimer-based particulates for drug delivery and noninvasive imaging. Biomaterials 2009, 30:3946–3955.
55. Vaupel P. The role of hypoxia-induced factors in tumor progression. Oncologist 2004, 9:10–17.
56. Naha PC, Bhattacharya K, Tenuta T, Dawson KA, Lynch I, Gracia A, Lyng FM, Byrne HJ. Intracellular localisation, geno- and cytotoxic response of polyN-isopropylacrylamide (PNIPAM) nanoparticles to human keratinocyte (HaCaT) and colon cells (SW 480). Toxicol Lett 2010, 198:134–143.
57. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008, 7:11–20.
58. Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell 2008, 134:703–707.
59. Kim J-W, Dang CV. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res 2006, 66:8927–8930.
60. Kojima C. A collagen-mimic dendrimer capable of controlled release. J Am Chem Soc 2009, 131:6052–6053.
61. Giatromanolaki A, Koukourakis MI, Sivridis E, Pastorek J, Wykoff CC, Gatter KC, Harris AL. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res 2001, 61(21):7992–7998.
62. Tian L, Bae YH. Cancer nanomedicines targeting tumor extracellular pH. Colloids Surf B Biointerfaces 2012, 99:116–126.
63. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004, 4:891–899.
64. Bae Y, Nishiyama N, Fukushima S, Koyama H, Yasuhiro M, Kataoka K. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. Bioconjug Chem 2005, 16:122–130.
65. Manchun S, Dass CR, Sriamornsak P. Targeted therapy for cancer using pH-responsive nanocarrier systems. Life Sci 2012, 90:381–387.
66. Mellman I, Fuchs R, Helenius A. Acidification of the endocytic and exocytic pathways. Annu Rev Biochem 1985, 55:663–700.
67. Cerletti a, Drewe J, Fricker G, Eberle a N, Huwyler J. Endocytosis and transcytosis of an immunoliposome-based brain drug delivery system. J Drug Target 2000, 8:435–446.
68. Bareford LM, Swaan PW. Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev 2007, 59:748–758.
69. Couvreur P, Vauthier C. Nanotechnology: intelligent design to treat complex disease. Pharm Res 2006, 23:1417–1450.
70. Quader S, Cabral H, Mochida Y, Ishii T, Liu X, Toh K, Kinoh H, Miura Y, Nishiyama N, Kataoka K. Selective intracellular delivery of proteasome inhibitors through pH-sensitive polymeric micelles directed to efficient antitumor therapy. J Control Release 2014, 188:67–77.
71. Hatakeyama H, Murata M, Sato Y, Takahashi M, Minakawa N, Matsuda A, Harashima H. The systemic administration of an anti-miRNA oligonucleotide encapsulated pH-sensitive liposome results in reduced level of hepatic microRNA-122 in mice. J Control Release 2013, 173:43–50.
72. Madhusudana Rao K, Krishna Rao KSV, Ramanjaneyulu G, Ha C-S. Curcumin encapsulated pH sensitive gelatin based interpenetrating polymeric network nanogels for anti cancer drug delivery. Int J Pharm 2015, 478:788–795.
73. Zou J, Zhang F, Zhang S, Pollack SF, Elsabahy M, Fan J, Wooley KL. Poly(ethylene oxide)-block-polyphosphoester-graft-paclitaxel conjugates with acid-labile linkages as a pH-sensitive and functional nanoscopic platform for paclitaxel delivery. Adv Healthc Mater 2014, 3:441–448.
74. Mukhopadhyay P, Chakraborty S, Bhattacharya S, Mishra R, Kundu PP. pH-sensitive chitosan/alginate core-shell nanoparticles for efficient and safe oral insulin delivery. Int J Biol Macromol 2015, 72:640–648.
75. Lin Z, Li J, He H, Kuang H, Chen X, Xie X, Jing X, Huang Y. Acetalated-dextran as valves of mesoporous silica particles for pH responsive intracellular drug delivery. RSC Adv 2015, 5:9546–9555.
76. Chacko RT, Ventura J, Zhuang JM, Thayumanavan S. Polymer nanogels: a versatile nanoscopic drug delivery platform. Adv Drug Deliv Rev 2012, 64:836–851.
77. Raemdonck K, Demeester J, Smedt SD. Advanced nanogel engineering for drug delivery. Soft Matter 2009, 5:707–715.
78. Soni G, Yadav KS. Nanogels as potential nanomedicine carrier for treatment of cancer: a mini review of the state of the art. Saudi Pharm J 2014. In Press.
79. Yallapu MM, Jaggi M, Chauhan SC. Design and engineering of nanogels for cancer treatment. Drug Discov Today 2001, 16:457–463.
80. Vinogradov SV. Colloidal microgels in drug delivery applications. Curr Pharm Des 2006, 12:4703–4712.
81. Abandansari HS, Nabid MR, Rezaei SJT, Niknejad H. pH-sensitive nanogels based on Boltorn® H40 and poly(vinylpyridine) using mini-emulsion polymerization for delivery of hydrophobic anticancer drugs. Polymer (Guildf) 2014, 55:3579–3590.
82. Rigogliuso S, Sabatino MA, Adamo G. Polymeric nanogels: nanocarriers for drug delivery application. Chem Eng Transact 2012, 27:247–252.
83. Lv Y, Huang H, Yang B, Liu H, Li Y, Wang J. A robust pH-sensitive drug carrier: aqueous micelles mineralized by calcium phosphate based on chitosan. Carbohydr Polym 2014, 111:101–107.
84. Wu H, Zhu L, Torchilin VP. pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery. Biomaterials 2013, 34:1213–1222.
85. Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 2001, 47:113–131.
86. Yang YQ, Zhao B, Li ZD, Lin WJ, Zhang CY, Guo XD, Wang JF, Zhang LJ. pH-sensitive micelles self-assembled from multi-arm star triblock co-polymers poly(ε-caprolactone)-b-poly(2-(diethylamino)ethyl methacrylate)-b-poly(poly(ethylene glycol) methyl ether methacrylate) for controlled anticancer drug delivery. Acta Biomater 2013, 9:7679–7690.
87. Liu GY, Li M, Zhu CS, Jin Q, Zhang ZC, Ji J. Charge-conversional and pH-sensitive PEGylated polymeric micelles as efficient nanocarriers for drug delivery. Macromol Biosci 2014, 14:1280–1290.
88. Kamimura M, Nagasaki Y. pH-Sensitive polymeric micelles for enhanced intracellular anti-cancer drug delivery. J Photopolym Sci Technol 2013, 26:161–164.
89. Lv S, Tang Z, Zhang D, Song W, Li M, Lin J, Liu H, Chen X. Well-defined polymer-drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxel. J Control Release 2014, 194:220–227.
90. Zou J, Jafr G, Themistou E, Yap Y, Wintrob ZA, Alexandridis P, Ceacareanu AC, Cheng C. pH-Sensitive brush polymer-drug conjugates by ring-opening metathesis copolymerization. Chem Commun (Camb) 2011, 47(15):4493–4495.
91. She W, Li N, Luo K, Guo C, Wang G, Geng Y, Gu Z. Dendronized heparin-doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy. Biomaterials 2013, 34:2252–2264.
92. Du C, Deng D, Shan L, Wan S, Cao J, Tian J, Achilefu S, Gu Y. A pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug delivery. Biomaterials 2013, 34:3087–3097.
93. Soppimath K, Aminabhavi T, Kulkarni A, Rudzinski W. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001, 70:1–20.
94. Liu R, Li D, He B, Xu X, Sheng M, Lai Y, Wang G, Gu Z. Anti-tumor drug delivery of pH-sensitive poly (ethylene glycol)-poly (L-histidine-)-poly (L-lactide) nanoparticles. J Control Release 2011, 152:49–56.
95. Dan X, Wu F, Chen Y, Wei L, Yuan W. pH-sensitive degradable nanoparticles for highly efficient intracellular delivery of exogenous protein. Int J Nanomedicine 2013, 8:3405.
96. Ramasamy T, Haidar ZS, Tran TH, Choi JY, Jeong JH, Shin BS, Choi HG, Yong CS, Kim JO. Layer-by-layer assembly of liposomal nanoparticles with PEGylated polyelectrolytes enhances systemic delivery of multiple anticancer drugs. Acta Biomater 2014, 10:5116–5127.
97. Blume G, Cevc G. Liposomes for the sustained drug release in vivo. Biochim Biophys Acta Biomembr 1990, 1029:91–97.
98. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005, 4:145–160.
99. VP T. Micellar nanocarriers: pharmaceutical perspectives. Pharm Res 2007, 24:1–16.
100. Sihorkaer V, Vyas SP. Potential of polysaccharide anchored liposomes in drugs delivery, targeting and immunization. J Pharm Pharm Sci 2001, 4:138–158.
101. Yoshizaki Y, Yuba E, Sakaguchi N, Koiwai K, Harada A, Kono K. Potentiation of pH-sensitive polymer-modified liposomes with cationic lipid inclusion as antigen delivery carriers for cancer immunotherapy. Biomaterials 2014, 35:8186–8196.
102. Watarai S, Iwase T, Tajima T, Yuba E, Kono K. Efficiency of pH-sensitive fusogenic polymer-modified liposomes as a vaccine carrier. Sci World J 2013, 2013, Article ID 903234, 7 pages.
103. Bersani S, Vila-Caballer M, Brazzale C, Barattin M, Salmaso S. pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine) decorated liposomes for the delivery of gemcitabine to cancer cells. Eur J Pharm Biopharm 2014, 88:670–682.
104. Deng Z, Zhen Z, Hu X, Wu S, Xu Z, Chu PK. Hollow chitosan-silica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapy. Biomaterials 2011, 32:4976–4986.
105. Zheng Q, Lin T, Wu H, Guo L, Ye P, Hao Y, Guo Q, Jiang J, Fu F, Chen G. Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release. Int J Pharm 2014, 463:22–26.
106. Yuan L, Tang Q, Yang D, Zhang JZ, Zhang F, Hu J. Preparation of pH-responsive mesoporous silica nanoparticles and their application in controlled drug delivery. J Phys Chem C 2011, 115:9926–9932.
107. Tang F, Li L, Chen D. Mesoporous silica nanoparticles: synthesis, biocom-patibility and drug delivery. Adv Mater 2012, 24:1504–1534.
108. 3 to bone minerals. Biomaterials 2010, 31:6628–6634.
109. Yang S, Chen D, Li N, Mei X, Qi X, Li H, Xua Q, Lu J. A facile preparation of targetable pH-sensitive polymeric nanocarriers with encapsulated magnetic nanoparticles for controlled drug release. J Mater Chem 2012, 22:25354.
110. Nowag S, Haag R. pH-responsive micro- and nanocarrier systems. Angew Chem Int Ed 2014, 53:49–51.
111. Sonaje K, Lin K, Wang JJ, Mi FL, Chen CT, Juang JH, Sung HW. Self-assembled pH-sensitive nanoparticles: a platform for oral delivery of protein drugs. Adv Funct Mater 2010, 20:3695–3700.
112. Shenoy D, Little S, Langer R, Amiji M. Poly(ethylene oxide)-modified poly(β-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 2. in vivo distribution and tumor localization studies. Pharm Res 2005, 22:2107–2114.
113. Dan K, Pan R, Ghosh S. Aggregation and pH responsive disassembly of a new acid-labile surfactant synthesized by thiol - acrylate michael addition reaction. Langmuir 2011, 27:612–617.
114. Ulbrich K, Subr V. Polymeric anticancer drugs with pH-controlled activation. Adv Drug Deliv Rev 2004, 56:1023–1050.
115. Tomlinson R, Heller J, Brocchini S, Duncan R. Polyacetal-doxorubicin conjugates designed for pH-dependent degradation. Bioconjug Chem 2003, 14:1096–1106.
116. Torchilin VP. Multifunctional nanocarriers. Adv Drug Deliv Rev 2012, 64:302–315.
117. Legendre J, Szoka FJ. Delivery of plasmid DNA into mammalian cell lines using pH-sensitive liposomes: comparison with cationic liposomes. Pharm Res 1992, 9:1235–1242.
118. Varkouhi A, Scholte M, Storm G, Haisma H. Endosomal escape pathways for delivery of biologicals. J Control Release 2011, 151:220–228.
119. Bae Y, Fukushima S, Harada A, Kataoka K. Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change. Angew Chem Int Ed Engl 2003, 42:4640–4643.
120. Chen W, Meng F, Cheng R, Zhong Z. pH-Sensitive degradable polymersomes for triggered release of anticancer drugs: a comparative study with micelles. J Control Release 2010, 142:40–46.
121. Zhang H, Wu H, Fan L, Li F, Gu C, Jia M. Preparation and characteristics of pH-sensitive derivated dextran hydrogel nanoparticles. Polym Compos 2009, 30:1243–1250.
122. Wang X-Q, Zhang Q. pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs. Eur J Pharm Biopharm 2012, 82:219–229.
123. Li MG, Lu WL, Wang JC, Zhang X, Zhang H, Wang XQ, Wu CS, Zhang Q. Preparation and characterization of insulin nanoparticles employing chitosan and poly(methylmethacrylate/methylmethacrylic acid) copolymer. J Nanosci Nanotechnol 2006, 6:2874–2886.
124. Ganta S, Devalapally H, Shahiwala A, Amiji M. A review of stimuli-responsive nanocarriers for drug and gene delivery. J Control Release 2008, 126:187–204.
125. Zhang S, Zhao Y. Rapid release of entrapped contents from multi-functionalizable, surface cross-linked micelles upon different stimulation. J Am Chem Soc 2010, 132:10642–10644.
126. Qiu Y, Park K. Environment-sensitive hydrogels for drug delivery. Adv Drug Deliv Rev 2001, 53:321–339.
127. Sun X, Wang H, Jing Z, Mohanathas R. Hemicellulose-based pH-sensitive and biodegradable hydrogel for controlled drug delivery. Carbohydr Polym 2013, 92:1357–1366.
128. Wang K, Xu X, Liu T, Fu S, Guo G, Gu Y, Luo F, Zhao X, Wei Y, Qian Z. Synthesis and characterization of biodegradable pH-sensitive hydrogel based on poly (e -caprolactone), methacrylic acid, and Pluronic (L35) q OH. Carbohydr Polym 2010, 79:755–761.
129. Kim D, Park K. Swelling and mechanical properties of superporous hydrogels of poly(acrylamide-co-acrylic acid)/polyethylenimine interpenetrating polymer networks. Polymer (Guildf) 2004, 45:189–196.
130. Faghihi S, Karimi A, Jamadi M, Imani R, Salarian R. Graphene oxide/poly(acrylic acid)/gelatin nanocomposite hydrogel: experimental and numerical validation of hyperelastic model. Mater Sci Eng C Mater Biol Appl 2014, 38:299–305.
131. Gutowska A, Barka JS, Kwona IC, Baea YH, Chab Y, Kima SW. Squeezing hydrogels for controlled oral drug delivery. J Control Release 1997, 48:141–148.
132. Sonaje K, Chen YJ, Chen HL, Wey SP, Juang JH, Nguyen HN, Hsu CW, Lin KJ, Sung HW. Enteric-coated capsules filled with freeze-dried chitosan/poly(γ-glutamic acid) nanoparticles for oral insulin delivery. Biomaterials 2010, 31:3384–3394.
133. Carelli V, Coltelli S, Di Colo G, Nannipieri E, Serafini MF. Silicone microspheres for pH-controlled gastrointestinal drug delivery. Int J Pharm 1999, 179:73–83.
134. Ashley CE, Carnes EC, Phillips GK, Padilla D, Durfee PN, Brown PA, Hanna TN, Liu J, Phillips B, Carter MB, Carroll NJ, Jiang X, Dunphy DR, Willman CL, Petsev DN, Evans DG, Parikh AN, Chackerian B, Wharton W, Peabody DS, Brinker CJ. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat Mater 2011, 10:389–397.
135. Wu X, Wang Z, Zhu D, Zong S, Yang L, Zhong Y, Cui Y. pH and thermo dual-stimuli-responsive drug carrier based on mesoporous silica nanoparticles encapsulated in a copolymer-lipid bilayer. ACS Appl Mater Interfaces 2013, 5:10895–10903.
136. Torchilin VP. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat Rev Drug Discov 2014, 13:813–827.
137. Chen X, Soeriyadi AH, Li X, Sagnella SM, Kavallaris M, Gooding JJ. Dual bioresponsive mesoporous silica nanocarrier as an ‘AND’ logic gate for targeted drug delivery cancer cells. Adv Funct Mater 2014, 24:6999–7006.
138. Zhou T, Zhao X, Liu L, Liu P. Preparation of biodegradable PEGylated pH/reduction dual-stimuli responsive nanohydrogels for controlled release of an anti-cancer drug. Nanoscale 2015, 7:12051–12060.
139. Li Z, Xu W, Wang Y, Shah BR, Zhang C, Chen Y, Li Y, Li B. Quantum dots loaded nanogels for low cytotoxicity, pH-sensitive fluorescence, cell imaging and drug delivery. Carbohydr Polym 2015, 121:477–485.
140. Hsieh CJ, Chen YC, Hsieh PY, Liu SR, Wu SP, Hsieh YZ, Hsu HY. Graphene oxide based nanocarrier combined with a pH-sensitive tracer: a vehicle for concurrent pH sensing and pH-responsive oligonucleotide delivery. ACS Appl Mater Interfaces 2015, 7:11467–11475.
141. Treiber C, Quadir MA, Voigt P, Radowski M, Xu S, Munter LM, Bayer TA, Schaefer M, Haag R, Multhaup G. Cellular copper import by nanocarrier systems, intracellular availability, and effects on amyloid β peptide secretion. Biochemistry 2009, 48:4273–4284.
142. Tang C, Amin D, Messersmith PB, Anthony JE, Prud'homme RK. Polymer directed self-assembly of pH-responsive antioxidant nanoparticles. Langmuir 2015, 31:3612–3620.
143. Wang Y, Chen L, Tan L, Zhao Q, Luo F, Wei Y, Qian Z. PEG–PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy. Biomaterials 2014, 35:6972–6985.
144. Koetting MC, Peppas NA. pH-Responsive poly(itaconic acid-co-N-vinylpyrrolidone) hydrogels with reduced ionic strength loading solutions offer improved oral delivery potential for high isoelectric point-exhibiting therapeutic proteins. Int J Pharm 2014, 471:83–91.
145. Gogoi N, Chowdhury D. Novel carbon dot coated alginate beads with superior stability, swelling and pH responsive drug delivery. J Mater Chem B 2014, 2:4089–4099.
146. Du J-Z, Du X-J, Mao C-Q, Wang J. Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery. J Am Chem Soc 2011, 133:17560–17563.
147. Yu H, Xu Z, Chen X, Xu L, Yin Q, Zhang Z, Li Y. Reversal of lung cancer multidrug resistance by pH-responsive micelleplexes mediating co-delivery of siRNA and paclitaxel. Macromol Biosci 2014, 14:100–109.
148. Gui W, Wang W, Jiao X, Chen L, Wen Y, Zhang X. Dual-cargo selectively controlled release based on a pH-responsive mesoporous silica system. ChemPhysChem 2015, 16:607–613.
149. Ju Y, Cui J, Müllner M, Suma T, Hu M, Caruso F. Engineering low-fouling and pH-degradable capsules through the assembly of metal-phenolic networks. Biomacromolecules 2015, 16:807–814.
150. Tu F, Lee D. Shape-changing and amphiphilicity-reversing Janus particles with pH-responsive surfactant properties. J Am Chem Soc 2014, 136:9999–10006.